JP2007504242A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007504242A5 JP2007504242A5 JP2006525453A JP2006525453A JP2007504242A5 JP 2007504242 A5 JP2007504242 A5 JP 2007504242A5 JP 2006525453 A JP2006525453 A JP 2006525453A JP 2006525453 A JP2006525453 A JP 2006525453A JP 2007504242 A5 JP2007504242 A5 JP 2007504242A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49996603P | 2003-09-03 | 2003-09-03 | |
| US49996003P | 2003-09-03 | 2003-09-03 | |
| PCT/US2004/028660 WO2005023314A1 (en) | 2003-09-03 | 2004-09-02 | Compounds containing matrix metalloproteinase substrates and methods of their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007504242A JP2007504242A (ja) | 2007-03-01 |
| JP2007504242A5 true JP2007504242A5 (https=) | 2007-04-12 |
Family
ID=34278690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525453A Pending JP2007504242A (ja) | 2003-09-03 | 2004-09-02 | マトリックスメタロプロテイナーゼ基質含有化合物およびそれらの使用法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050106100A1 (https=) |
| EP (1) | EP1691845A4 (https=) |
| JP (1) | JP2007504242A (https=) |
| AU (1) | AU2004270200A1 (https=) |
| CA (1) | CA2537771A1 (https=) |
| WO (1) | WO2005023314A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1522857A1 (en) * | 2003-10-09 | 2005-04-13 | Universiteit Maastricht | Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2 |
| EP1940841B9 (fr) | 2005-10-07 | 2017-04-19 | Guerbet | Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium |
| US8986650B2 (en) | 2005-10-07 | 2015-03-24 | Guerbet | Complex folate-NOTA-Ga68 |
| CA2644694C (en) * | 2006-03-10 | 2014-05-13 | Sangeeta N. Bhatia | Triggered self-assembly conjugates and nanosystems |
| US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| CA2648385C (en) | 2006-04-04 | 2020-09-01 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| GB0707034D0 (en) | 2007-04-12 | 2007-05-23 | St Andrews The | Compounds |
| WO2009007846A2 (en) * | 2007-06-15 | 2009-01-15 | Universitetet If Oslo | Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins |
| CA2697032C (en) * | 2007-08-22 | 2021-09-14 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
| WO2009029936A1 (en) * | 2007-08-31 | 2009-03-05 | Case Western Reserve University | In vivo imaging of myelin |
| US8361438B2 (en) | 2008-01-08 | 2013-01-29 | Lantheus Medical Imaging, Inc. | N-alkoxyamide conjugates as imaging agents |
| GB0819287D0 (en) | 2008-10-22 | 2008-11-26 | Univ Bradford | Compounds |
| CN104198712A (zh) * | 2008-10-29 | 2014-12-10 | Bg医药股份有限公司 | 半乳凝素-3免疫测定法 |
| US20100189651A1 (en) * | 2009-01-12 | 2010-07-29 | Cytomx Therapeutics, Llc | Modified antibody compositions, methods of making and using thereof |
| JP5861223B2 (ja) * | 2009-02-23 | 2016-02-16 | サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. | プロタンパク質およびその使用方法 |
| JP5678045B2 (ja) | 2009-06-08 | 2015-02-25 | シンギュレックス・インコーポレイテッド | 高感度バイオマーカーパネル |
| CA2803520C (en) | 2009-07-08 | 2019-10-22 | Lantheus Medical Imaging, Inc. | N-alkoxyamide conjugates as imaging agents |
| BR112012008063A2 (pt) * | 2009-08-25 | 2016-11-22 | Bg Medicine Inc | galectina-3 e terapia de ressincronização cardíaca. |
| US20150023873A1 (en) | 2011-11-11 | 2015-01-22 | Lantheus Medical Imaging, Inc. | Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| GB2516882A (en) | 2013-08-02 | 2015-02-11 | Univ Bradford | Tumour-targeted theranostic |
| RU2607041C2 (ru) * | 2015-05-29 | 2017-01-10 | Общество с ограниченной ответственностью "Научно-производственная фирма ДНК-Технология" | Способ определения степени гноетечения на пародонте по уровню мРНК гена интерлейкина-8 (IL-8) человека |
| WO2018148596A1 (en) * | 2017-02-10 | 2018-08-16 | Boston Scientific Scimed, Inc. | Vascular ulcer treatment |
| EP3774838B9 (en) | 2018-04-10 | 2025-12-10 | Sanofi-Aventis Deutschland GmbH | Lixisenatide synthesis with capping |
| WO2020160232A1 (en) * | 2019-02-01 | 2020-08-06 | Glympse Bio, Inc. | Detecting architectural remodelling in cells extracellular matrix, and the tissue microenvironment |
| IN202021002695A (https=) * | 2020-01-21 | 2021-07-23 | ||
| JP2023550412A (ja) * | 2020-11-19 | 2023-12-01 | ノバルティス アーゲー | 前立腺特異的膜抗原（ｐｓｍａ）リガンドの合成 |
| WO2025085511A1 (en) * | 2023-10-18 | 2025-04-24 | University Of Washington | Systems and methods for polymer-mediated activation of engineered cells |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859777A (en) * | 1981-07-01 | 1989-08-22 | Eastman Kodak Company | Terpyridine chelating agents |
| US4452774A (en) * | 1982-04-30 | 1984-06-05 | President And Fellows Of Harvard College | Isonitrile radionuclide complexes for labelling and imaging agents |
| EP0247156B1 (en) * | 1985-11-18 | 1993-06-23 | Access Pharmaceuticals Inc. | Polychelating agents for image and spectral enhancement (and spectral shift) |
| CA1305160C (en) * | 1985-12-23 | 1992-07-14 | Paul Louis Bergstein | Ether isonitriles and radiolabeled complexes thereof |
| US4913891A (en) * | 1986-04-17 | 1990-04-03 | The United States Of America As Represented By The United States Department Of Energy | Positron emitter labeled enzyme inhibitors |
| US5567411A (en) * | 1986-11-10 | 1996-10-22 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group |
| US5252317A (en) * | 1986-11-10 | 1993-10-12 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid |
| US5064956A (en) * | 1987-06-24 | 1991-11-12 | The Dow Chemical Company | Process for preparing mono-n-alkylated polyazamacrocycles |
| US5087440A (en) * | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
| GB8923843D0 (en) * | 1989-10-23 | 1989-12-13 | Salutar Inc | Compounds |
| GB9006977D0 (en) * | 1990-03-28 | 1990-05-23 | Nycomed As | Compositions |
| EP0577675B1 (en) * | 1991-03-27 | 1999-12-08 | Nycomed Salutar Inc. | Contrast media |
| GB9209641D0 (en) * | 1992-05-02 | 1992-06-17 | Johnson Matthey Plc | Improvements in radiolabelling |
| US5760191A (en) * | 1993-02-05 | 1998-06-02 | Nycomed Imaging As | Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
| US5750088A (en) * | 1993-03-30 | 1998-05-12 | The Dupont Merck Pharmaceutical Company | Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals |
| US5744120A (en) * | 1993-03-30 | 1998-04-28 | The Dupont Merick Pharmaceutical Company | Ternary radiopharmaceutical complexes |
| EP0692978A4 (en) * | 1993-03-31 | 1998-05-06 | Mallinckrodt Medical Inc | RADIOPHARMACEUTICAL PREPARATIONS THAT DO NOT CONTAIN TIN REDUCER |
| US5417959A (en) * | 1993-10-04 | 1995-05-23 | Mallinckrodt Medical, Inc. | Functionalized aza-crytand ligands for diagnostic imaging applications |
| US5520904A (en) * | 1995-01-27 | 1996-05-28 | Mallinckrodt Medical, Inc. | Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging |
| SE515621C2 (sv) * | 1995-05-08 | 2001-09-10 | Ericsson Telefon Ab L M | Förfarande vid lägesbestämning |
| US5801228A (en) * | 1995-06-07 | 1998-09-01 | Nycomed Imaging As | Polymeric contrast agents for medical imaging |
| IT1275571B (it) * | 1995-07-19 | 1997-08-07 | Consiglio Nazionale Ricerche | Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori |
| AU726914B2 (en) * | 1996-04-01 | 2000-11-23 | Epix Pharmaceuticals, Inc. | Bioactivated diagnostic imaging contrast agents |
| US5804161A (en) * | 1996-05-14 | 1998-09-08 | Nycomed Salutar Inc. | Contrast agents |
| DE19717904A1 (de) * | 1997-04-23 | 1998-10-29 | Diagnostikforschung Inst | Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie |
| US6083486A (en) * | 1998-05-14 | 2000-07-04 | The General Hospital Corporation | Intramolecularly-quenched near infrared fluorescent probes |
| US5980863A (en) * | 1998-11-02 | 1999-11-09 | Eagle Vision Pharmaceutical Corporation | Manganese compositions and methods for MRI |
| US6254852B1 (en) * | 1999-07-16 | 2001-07-03 | Dupont Pharmaceuticals Company | Porous inorganic targeted ultrasound contrast agents |
| US6656448B1 (en) * | 2000-02-15 | 2003-12-02 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
| WO2002072014A2 (en) * | 2001-03-08 | 2002-09-19 | Volcano Therapeutics, Inc. | Medical devices, compositions and methods for treating vulnerable plaque |
-
2004
- 2004-09-01 US US10/931,627 patent/US20050106100A1/en not_active Abandoned
- 2004-09-02 WO PCT/US2004/028660 patent/WO2005023314A1/en not_active Ceased
- 2004-09-02 AU AU2004270200A patent/AU2004270200A1/en not_active Abandoned
- 2004-09-02 EP EP04783037A patent/EP1691845A4/en not_active Withdrawn
- 2004-09-02 CA CA002537771A patent/CA2537771A1/en not_active Abandoned
- 2004-09-02 JP JP2006525453A patent/JP2007504242A/ja active Pending